Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$413K Sell
37,242
-2,187,368
-98% -$27.9M ﹤0.01% 914
2025
Q4
$36.5M Sell
2,224,610
-271,015
-11% -$4.22M 0.13% 124
2025
Q3
$33.4M Buy
2,495,625
+97,357
+4% +$1.15M 0.13% 129
2025
Q2
$30.7M Buy
2,398,268
+58,934
+3% +$707K 0.12% 130
2025
Q1
$24.1M Buy
2,339,334
+1,192,280
+104% +$15.3M 0.11% 156
2024
Q4
$14.6M Buy
1,147,054
+662,788
+137% +$8.76M 0.07% 202
2024
Q3
$6.2M Sell
484,266
-70,018
-13% -$857K 0.04% 342
2024
Q2
$7.03M Buy
554,284
+533,445
+2,560% +$9.22M 0.04% 305
2024
Q1
$472K Buy
+20,839
New +$488K ﹤0.01% 630

Other funds holding PATH

Ray Dalio's PATH Position: Q1 2026 in Review

Ray Dalio reduced its UiPath (PATH) stake by 98% in Q1 2026, selling an estimated $27.9M and leaving 37,242 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Ray Dalio first reported a position in PATH in Q1 2024 and has held it in 9 quarters since. The position peaked at $36.5M in Q4 2025. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Ray Dalio held 37,242 shares of UiPath worth $413K as of Q1 2026.
  • Ray Dalio sold 2,187,368 UiPath shares in Q1 2026, an estimated $27.9M.
  • UiPath made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #914 holding.
  • Ray Dalio first reported a position in UiPath in Q1 2024 and has held it in 9 quarters since.
  • Ray Dalio's UiPath position peaked at $36.5M in Q4 2025.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.